Credit Suisse’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,331
Closed -$113K 3147
2023
Q2
$113K Sell
9,331
-2,763
-23% -$31.4K ﹤0.01% 3130
2023
Q1
$154K Hold
12,094
﹤0.01% 3162
2022
Q4
$76.4K Hold
12,094
﹤0.01% 3365
2022
Q3
$273K Sell
12,094
-1
-0% -$27 ﹤0.01% 3120
2022
Q2
$232K Sell
12,095
-48
-0.4% -$1.19K ﹤0.01% 3278
2022
Q1
$563K Sell
12,143
-8
-0.1% -$437 ﹤0.01% 2903
2021
Q4
$861K Buy
12,151
+2,378
+24% +$239K ﹤0.01% 3429
2021
Q3
$1.14M Buy
9,773
+7,159
+274% +$834K ﹤0.01% 3238
2021
Q2
$409K Sell
2,614
-81
-3% -$14.9K ﹤0.01% 3952
2021
Q1
$510K Sell
2,695
-932
-26% -$157K ﹤0.01% 3753
2020
Q4
$455K Buy
3,627
+191
+6% +$21.7K ﹤0.01% 3844
2020
Q3
$374K Buy
3,436
+2,168
+171% +$257K ﹤0.01% 3534
2020
Q2
$152K Buy
1,268
+140
+12% +$19.7K ﹤0.01% 3791
2020
Q1
$113K Buy
+1,128
New +$209K ﹤0.01% 3795

Other funds holding DNTH